Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum toxin injection into pylorus for diabetic gastroparesis
2004-004217-42Phase 4Completed
- Sponsor
- University Hospital Vienna
- Start
- Mar 2005
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, single-arm trial of botulinum toxin type A in diabetic gastroparesis, diabetes mellitus type 1 (T1D) and type 2 diabetes mellitus (T2DM), sponsored by University Hospital Vienna. Started Mar 2005; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
diabetic gastroparesisdiabetes mellitus type 1 (T1D)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2004-004217-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004217-42.